- Home
- NYXH vs ACCD Comparison
NYXH vs ACCD Comparison
Compare NYXH & ACCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYXH
- ACCD
- Stock Information
- Founded
- NYXH 2009
- ACCD 2007
- Country
- NYXH Belgium
- ACCD United States
- Employees
- NYXH N/A
- ACCD N/A
- Industry
- NYXH Medical/Dental Instruments
- ACCD Business Services
- Sector
- NYXH Health Care
- ACCD Consumer Discretionary
- Exchange
- NYXH Nasdaq
- ACCD Nasdaq
- Market Cap
- NYXH 261.1M
- ACCD 286.7M
- IPO Year
- NYXH 2021
- ACCD 2020
- Fundamental
- Price
- NYXH $8.22
- ACCD $3.47
- Analyst Decision
- NYXH Strong Buy
- ACCD Buy
- Analyst Count
- NYXH 5
- ACCD 12
- Target Price
- NYXH $17.00
- ACCD $9.04
- AVG Volume (30 Days)
- NYXH 26.6K
- ACCD 1.3M
- Earning Date
- NYXH 11-06-2024
- ACCD 01-06-2025
- Dividend Yield
- NYXH N/A
- ACCD N/A
- EPS Growth
- NYXH N/A
- ACCD N/A
- EPS
- NYXH N/A
- ACCD N/A
- Revenue
- NYXH $5,668,079.00
- ACCD $441,028,000.00
- Revenue This Year
- NYXH $37.10
- ACCD $15.56
- Revenue Next Year
- NYXH $418.12
- ACCD $11.76
- P/E Ratio
- NYXH N/A
- ACCD N/A
- Revenue Growth
- NYXH 32.65
- ACCD 16.04
- 52 Week Low
- NYXH $4.00
- ACCD $3.08
- 52 Week High
- NYXH $20.00
- ACCD $15.36
- Technical
- Relative Strength Index (RSI)
- NYXH 30.23
- ACCD 47.12
- Support Level
- NYXH $8.10
- ACCD $3.08
- Resistance Level
- NYXH $10.01
- ACCD $3.80
- Average True Range (ATR)
- NYXH 0.47
- ACCD 0.17
- MACD
- NYXH -0.19
- ACCD 0.05
- Stochastic Oscillator
- NYXH 6.28
- ACCD 54.17
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
About ACCD Accolade Inc.
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.